Animal Friends Insurance (AFI), a not-for-profit pet insurance business, has a High Court injunction which paves the way for its customers to make a smooth transition from the company's previous underwriters, Equine and Livestock Insurance Company (E&L), to Red Sands Insurance Company (Europe) Limited.
Equine and Livestock terminated their underwriting agreement with AFI in February 2008, citing unprofitablility of the book for them as the reason.
Negotiations over the transfer of the book to Red Sands Insurance Company (Europe) Limited foundered when E&L demanded £750,000 from AFI for the transfer and for their agreement not to solicit AFI customers.
Following legal advice AFI wrote to its customers offering to renew policies with Red Sands. This spawned letters to AFI customers from E&L which caused great confusion amongst customers as to what was happening with their insurance. The letters also offered first a 10% then a 20% discount to tempt AFI customers to renew with E&L and not to stay with AFI.
AFI therefore applied for an emergency injunction to prevent E&L making further contact with AFI customers (except in agreed situations, notably claims), to stop the escalating confusion and also to require them to acknowledge renewals advised to them by AFI into Red Sands and not to take further payments on those insurances. The application was successful.
Elaine Fairfax, Managing Director and Founder of AFI said: "I am delighted at the Court ruling. It has resolved the terrible confusion that followed E&L's letters to our customers. Unfortunately we know that some customers said they would renew with E&L thinking they were staying with us! Now we can simply renew our customers' policies with our new underwriters as we had originally intended to do at no inconvenience to them as they need do nothing if they want to stay with Animal Friends. They will enjoy exactly the same policy terms and premiums as before and our underwriters will even take on existing ongoing conditions where a policyholder has lifetime cover."
She added: "Although this has been a horrible experience we are delighted to have new underwriters as they have given us authority to handle everything in-house. For vets this means that Animal Friends will now be handling claims at our Wiltshire H.Q. We have a bespoke pet claims software systems and veterinary nurse staff to give the best possible service. We have the facility to pay claims swiftly direct into a customer's bank account or direct to a vet. It is also exciting that we shall be able to draw on Hollard's* international pet insurance experience to introduce some unique new products and ideas into the UK pet insurance market in the near future."
The Veterinary Nurses Council of the RCVS is seeking nominations from veterinary surgeons and VNs for its Golden Jubilee award by 8 May 2012.
The award recognises an exceptional contribution made to the veterinary nursing profession and/or a positive contribution to animal welfare. The Golden Jubilee award was inaugurated to mark the 50th anniversary of veterinary nurse training, in 2011, and the first award was presented to Jean Turner in 2011 for her lifetime contribution to veterinary nursing.
Liz Branscombe, Chairman of the VN Council said: "This is a prestigious award and a great opportunity to recognise someone who has made a positive impact on our profession.
"VN Council feels strongly that the award should be accessible to a wide spectrum of individuals, so nominees could come from veterinary nurses or veterinary surgeons involved in clinical practice, research, teaching or politics - in fact, any aspect of veterinary nursing."
Both veterinary surgeons and VNs are eligible to make nominations, or to be nominated for the Golden Jubilee award; nominations should be received by 8 May 2012. More information, together with the nomination form, can be found at www.rcvs.org.uk/jubileeaward.
The award will be presented at RCVS Day on 6 July 2012.
Life Technologies Animal Health has announced the launch of a new qPCR test to improve the diagnosis of mastitis and respiratory disease caused by Mycoplasma bovis.
According to the company, the TaqVet Mycoplasma Bovis (M. bovis) polymerase chain reaction (PCR) kit is based on a new target gene in the M. bovis genome and thus can distinguish better between infections caused by M. bovis and M. agalactiae - so there is less risk of false positive results and improved sensitivity and specificity.
The test is based on real-time PCR technology, and delivers results in two and a half hours.
Eric Sellal, Head of Animal Health EMEA at Life Technologies said: "The improved sensitivity of this new test means that veterinarians will be able to monitor dairy herds for sub-clinical infection using samples from the bulk tank. And of course it can also be used to diagnose mycoplasma infection in individual cases of clinical mastitis and respiratory disease."
Life Technologies says the test system incorporates a number of other improvements which simplify and speed up processing in the laboratory, including automatic extraction using magnetic bead technology.
It is estimated that bovine pneumonia costs the European industry around 500million Euros each year, with 30% accounted for by M. bovis. Other diseases associated with the organism include mastitis and arthritis.
Mycoplasma is slow and difficult to culture in the laboratory and current antibiotic treatment is not very cost-effective. Therefore, prevention is a cornerstone of M. bovis management.
The TaqVet Mycoplasma Bovis PCR kit will be made available in other EU countries and via Life Technologies Animal Health distributors according to local regulatory requirements (see www.lifetechnologies.com/lsi-animal-health) for details.
With Brexit negotiations set to begin after notice under Article 50 of the Lisbon Treaty is served, the Prime Minister’s speech outlined the Government’s negotiating priorities that included some key BVA issues, such as: rights for EU nationals in Britain, and British nationals in the EU; the intention to continue playing a leading role in science and innovation; and maintaining the Common Travel Area with the Republic of Ireland.
The BVA’s President Gudrun Ravetz said: "It’s encouraging to see some of the key priorities that BVA has identified and is lobbying on, on behalf of the profession, make it into the Prime Minister’s list of negotiating priorities although it still leaves a lot of uncertainty.
"We particularly welcome the Prime Minister’s commitment to guaranteeing the rights of EU colleagues already living, working and studying in the UK, alongside reciprocal rights for UK colleagues working within the EU, which has been a BVA priority since day one. Each year around 50% of veterinary surgeons registering to practise in the UK are from overseas, with the vast majority coming from the EU. Consequently, Brexit and accompanying changes to the mutual recognition system or immigration restrictions could have a profound impact upon the veterinary workforce.
"As a science and evidence-based profession, we also welcome the Prime Minister’s recognition of the breadth and depth of our academic and scientific communities, our cutting-edge research and innovation, and we will continue to call for a regulatory and legislative framework to ensure the UK remains a globally attractive place for research and development.
"Knowing the express concern of colleagues in Northern Ireland, which shares a border with the EU via the Republic of Ireland, we were reassured by the UK government’s recognition of this as an important priority – backed up by Mrs May’s commitment to work with the devolved nations and secure the Common Travel Area as soon as she can.
"We hope Mrs May’s promise of ‘certainty wherever possible’ will help reassure our EU and UK veterinary colleagues – as well as those outside of the profession – who have had anything but certainty since the result of the UK referendum on the EU last June. We will continue to lobby the Government on this key issue until it is resolved."
BVA’s Brexit Working Group is continuing to work closely with RCVS’s Brexit Presidential Taskforce, consult with stakeholders and gather evidence with the aim of publishing a full report setting out our detailed lobbying position and policy recommendations in April.
Starting in the New Year, the benefits of vaccination will be communicated to both farmers and pet owners, initially focussing on farm use.
The aims of the campaign are to raise awareness of how and why vaccines work and the range of diseases they protect against, to review and improve how vaccines are stored and administered, and to encourage better uptake of existing vaccines.
Further information and tips on storing and using vaccines correctly will be shared, to help ensure that vaccines used will be effective.
NOAH says that research has shown that:
Dawn Howard, NOAH’s Chief Executive said: “It is encouraging that vaccination of the UK’s calves and sheep against livestock diseases has risen to one of the highest levels in seven years1. This increase is encouraging, however still more needs to be done in relation to uptake, storage and usage. We are asking the vet profession to support the #VaccinesWork campaign by spreading the messages with their clients and engaging on social media."
"We will be providing information for farmers e.g. if vaccines are not stored correctly, it will impact on their potency, meaning they could be less effective – not only will there be the potential for the vaccine to fail to protect animals against disease but also farmers may have wasted their efforts – and may be deterred from vaccinating again."
Whilst correct use by farmers is the initial focus, the campaign will include pets. Dawn said: "The topic of vaccine hesitancy is becoming increasingly important. Recognised by the WHO as one of the top 10 global health threats for people in 2019, this phenomenon is translating to the veterinary sector as well, especially in companion animals. The PDSA reports an ‘alarming’ drop in pet vaccinations: the proportion of pet dogs, cats and rabbits receiving a primary course when young has fallen by 18% over the past 3 years, down to 66%3.”
"This is bad news for the health and welfare of the nation’s pets, who are increasingly at risk of disease, and we need to work to address this."
References
https://ahdb.org.uk/knowledge-library/use-of-vaccines-in-cattle-and-sheep-2018-sales-update
https://www.noah.co.uk/wp-content/uploads/2019/10/NOAH-Vision-Paper-8pp-A4-Sep-19-vf.pdf
https://www.pdsa.org.uk/media/7420/2019-paw-report_downloadable.pdf
Five time European champion and British record-holding athlete, Laura Muir MRCVS, will be in conversation with Gudrun Ravetz and Rob Pope for a keynote session at the virtual event. The line-up also includes Bake-Off star, Rosie Brandreth-Poynter, alongside a number of other expert session leaders for personal development, baking, exercise, crafts and social elements.
The day long programme will start with a run, meditation or yoga. The plenary sessions and workshops include topics such as change management, establishing a ‘new normal', and how to build wellbeing into daily life.
Wellvet co-founder Ru Tipney said: "We're delighted to host an event which brings together so many amazing people to lead valuable - and potentially life-changing sessions - for delegates. We have content for everyone, from student sessions to workshops designed for practice managers and owners."
To include a social aspect, the virtual conference platform provides opportunities for networking and connecting with fellow delegates during and after the event. Ru said: "The vibe we've had at the last two WellVet events has been pretty special. WellVet works because of the mutual encouragement, openness and support of delegates. We're delighted to have found a platform to give a rich social experience alongside all the great content."
The content and networking functions are available for a year after the event and the organisers are keen to stress there's no need to sit through the whole day in one go. Delegates are invited to dip in and out, revisit sessions, and connect with others afterwards. Tickets are subsidised at £40 for a full delegate pass and £10 for students and new graduates.
For more information and to buy tickets, visit: www.wellvet.co.uk
Dechra Pharmaceuticals has signed an agreement with Piedmont Pharmaceuticals LLC which gives Dechra exclusive worldwide rights to the sale and distribution of veterinary products which use Piedmont's proprietary soft chew platform to deliver the active ingredient.
The agreement will allow Dechra to conduct studies necessary to achieve regulatory filings and government approvals within the US, Europe and other key countries.
According to Dechra, Piedmont's soft chew formulation is a unique delivery technology which overcomes the traditional problems in formulating a broad range of active drug compounds in a highly palatable chewy treat for both cats and dogs.
Ian Page, CEO of Dechra Pharmaceuticals PLC, said: "We are very excited about licensing this unique delivery technology, which will be the first soft chew product with this new patent pending technology in the veterinary market. The agreement will provide Dechra with the opportunity to expand our presence in the companion animal market with a truly differentiated product."Roland Johnson, Chairman and CEO of Piedmont Pharmaceuticals, said: "This is our initial development partnership for our soft chew technology and we welcome the opportunity to license our technology to Dechra. Our goal is to provide pet owners the added benefit of a tasty treat at medicine time, creating a fun and rewarding interaction, while improving compliance with the vet prescribed treatment regimen."
Genitrix has launched a free epilepsy faxback advice service for veterinary practices prescribing Libromide.
A form downloadable from the Genitrix website will enable practices to provide detailed case histories, and challenging canine epilepsy cases will be reviewed by Dr Clare Rusbridge, RCVS and European Specialist in veterinary neurology. Clare runs a small animal neurology referral practice based at the Stone Lion Veterinary Hospital in South London. She is board certified by the European College of Veterinary Neurology.
Launched earlier this year, Libromide is the first and only licensed formulation of potassium bromide for refractory canine epilepsy. Rob Watkins, Marketing Director at Genitrix, said: "When we launched Libromide, it was our goal to ensure that generalist practices, which may not deal with cases every week, were given more accurate guidance and advice on treating canine epilepsy than was possible when only unlicensed products were available.
"Our subsequent launch of the discounted blood test, the dosing wheel and now the Libromide Epilepsy Advice Service through Clare, are examples of our commitment to achieving this goal.
"The advice service is aimed specifically at practices which are finding it difficult to control seizures or which have a patient experiencing unusual side effects, even after receiving dosing advice from Genitrix. I hope that having Clare's experience and expertise 'on tap' for challenging cases will prove reassuring for our customers."
For more information on the Libromide Epilepsy Advice Service, practices are asked to call Genitrix' head office on 01403 786345.
Swindon-based Eastcott Veterinary Referrals is looking for a new resident to join its dentistry team.
Eastcott’s dentistry department is led by Andrew Perry, an EBVS European Veterinary Specialist in Dentistry. He's supported by Peter Southerden, AVDC Founding Fellow in Oral and Maxillofacial Surgery – one of only 14 founding fellows in the world and the only one practicing in Europe.
The residency programme will offer an in-depth knowledge in veterinary dentistry through a mix of clinical and non-clinical work.
It will also provide an opportunity to work alongside world class surgeons responsible for some of the most advanced dental surgical procedures of today.
The clinical aspect of the role will require the candidate to manage cases and perform all forms of dental and oral surgical procedures and client communication, with guidance from senior staff.
The role will also involve preparation of scientific articles for publication and will help develop the candidate's teaching and presenting skills and externships in diagnostic imaging, surgery and anaesthesia.
Andrew said: “The team at Eastcott are proud to be a part of developing future specialists in a discipline that is growing rapidly and has such an impact on patient welfare.
“Our multidisciplinary approach to management of dental, oral and maxillofacial pathologies means that the successful candidate will have the benefit of exposure to a very diverse, and at times cutting edge, caseload.
“The residency programme is well-established at Eastcott. The dentistry, oral and maxillofacial team, the hospital directors and the Linnaeus central support team are committed to individual development and growth and work hard to provide an environment and support to allow our residents to flourish.”
For more information on this role, visit www.eastcottreferrals.co.uk or email andrew.perry@eastcottvets.co.uk before July 31.
Ki-67 is a proliferation marker used for assessing tumour aggressiveness, however the traditional method of assessing Ki-67 scores involves manually counting the proliferating cells, which is subjective, time-consuming and prone to variability.
Finn says its new AI-assisted Ki-67 scoring test represents a significant advancement in veterinary diagnostic oncopathology.
The AI algorithm analyses Ki-67 labelling across the entire section of tumour.
Positively labelled cells are highlighted, scores are calculated, and the results are validated by a pathologist before reporting.
This more automated analysis enables the evaluation of large volumes of histological data, ensuring consistent and reliable prognostic assessments.
Finn says it also removes the subjectivity and variability associated with identifying areas of highest cell proliferation, which is a crucial aspect of tumour scoring.
https://www.finnpathologists.com
Virbac Animal Health is offering a client e-shot and text alert service for practices taking part in its Canine Prostate Awareness Month initiative this year.
Canine Prostate Awareness Month takes place during November 2012 following its debut last year when more than 400 practices signed up to support it.
Timed to coincide with 'Movember' when thousands of men grow moustaches to raise funds for male prostate and testicular cancer, Canine Prostate Awareness Month aims to highlight the prevalence of the disease in dogs and to encourage practices and owners to test for it. In addition to the new e-shot and text alert service, Virbac already provides post card reminders; free dog leads; educational and display materials and a press release for use by practices with their local media.
Participating practices that diagnose a dog with Benign Prostatic Hyperplasia during Canine Prostate Awareness Month are being asked to contact Virbac with details, as the company plans to collate a series of case studies from the initiative this year. The five best cases studies submitted before the end of the year will win Love2Shop vouchers to the value of £50.
Chris Geddes MRCVS, Virbac Product Manager, said: "There's a lot of interest already in this year's Canine Prostate Awareness Month so we're working hard to ensure it's even bigger and better than last year.
The serious message is that more than 80% of entire male dogs over the age of five suffer from Benign Prostatic Hyperplasia¹. Canine Prostate Awareness Month gives practices a reason to highlight the risk and encourage owners to test for it. Timing Canine Prostate Awareness Month to coincide with Movember is a good way to interest dog owners at a time when some might be considering the state of their own prostate."
For further information on Canine Prostate Awareness Month, email cpam@virbac.co.uk; contact your Virbac Territory Manager or contact the company direct on 01359 243243.
Reference
1. O'Shea J.D. Studies on the canine prostate gland: Factors influencing its size and weight. J. Comp. Pathol. 1962 72: 321-331.
The Royal Veterinary College and the Animal Health Trust are trying to recruit 3000 horse and pony owners to take part in 'CARE about laminitis', a web-based research project that aims to reduce the threat caused by laminitis.
The four-year study, which is being funded by World Horse Welfare, is being conducted by PhD student, Danica (Dee) Pollard, based at the AHT. The main aims of the study are to:
Currently the veterinary-reported frequency of laminitis in Britain, estimated between 2009 and 2011, shows that active episodes of veterinary-diagnosed laminitis occurred in nearly 1 in 200 horses/ponies registered with veterinary practices, and accounted for nearly 1 in 200 equine visits. Dee said: "However an overall lack of studies into the frequency of laminitis leaves little to compare these estimates with."
If you'd like to take part in the study, or invite clients to do so, visit: www.careaboutlaminitis.org.uk or email danica.pollard@aht.org.uk.
Nominations can be made for three RCVS Honours: the Queen’s Medal, the Golden Jubilee Award and Honorary Associateship.
The Queen’s Medal was introduced in 2013 and is the highest honour that the College can bestow upon a veterinary surgeon in recognition of those who have achieved a highly distinguished career and outstanding achievements. Nominations can be made by any Member of the RCVS in respect of another veterinary surgeon. The 2016 winner of the award was Professor Randolph Richards who was honoured for his contribution to the development of aquaculture in Scotland.
The Golden Jubilee Award was introduced in 2011 to mark the 50th anniversary of the first RCVS training course for veterinary nurses and now recognises those nurses who are taking a leadership role within the profession. The 2016 winner of the award was Louise O’Dwyer who was recognised for her pioneering role within the profession. Nominations can be made by either veterinary nurses or veterinary surgeons in respect of a veterinary nurse.
Nominations can also be made for Honorary Associateship which is eligible for those who, while not veterinary surgeons or nurses, have made a significant impact in the veterinary field. Previous winners have included scientists, farmers, farriers, educationalists and journalists. This year an Honorary Associateship was awarded to Professor David Lane for his support in launching the College’s Certificate in Advanced Veterinary Practice.
Further information about making nominations for each of these awards, including nominations forms, can be found at www.rcvs.org.uk/honours.
The deadline for nominations is Friday 16 September 2016 and all awards will be bestowed at RCVS Day 2017 in July next year.
Those with questions about making a nomination can contact Peris Dean, Executive Secretary, on p.dean@rcvs.org.uk.
The researchers hope that the study will help to increase a veterinary surgeon’s index of suspicion of a particular liver disease, particularly if a biopsy-confirmed diagnosis is not possible.
In the study titled “Histopathological frequency of canine hepatobiliary disease in the United Kingdom”, histopathology reports from canine liver tissues submitted to a commercial veterinary laboratory by UK first and second opinion practices were retrospectively reviewed.
Data collected included breed, age, sex, gross and histological descriptions, diagnosis and additional comments.
Data were then grouped into 23 categories according to WSAVA histological criteria for canine hepatobiliary diseases using the four main morphological groups of vascular, biliary, parenchymal and neoplastic disorders. Breed analysis was then performed on the top five ranking breeds within each individual category.
A total of 4584 histopathology reports of canine liver tissue were included in the analysis.
The most common histopathological diagnoses were reactive hepatitis (16.8%), chronic hepatitis (16.0%) and reversible hepatocellular injury (RHI) (12.9%).
Labrador retrievers were found to have increased odds for reactive hepatitis (OR 1.57, 95%CI 1.23-1.99), whilst crossbreeds demonstrated reduced odds (OR 0.65, 95%CI 0.54-0.79).
Breeds with increased odds of chronic hepatitis included the Labrador retriever (OR 4.14, 95%CI 3.47-4.93), springer spaniel (OR 6.30, 95%CI 5.10-7.79), cocker spaniel (OR 2.78 95%CI 2.20-3.53) and West Highland White Terrier (OR 3.23, 95%CI 2.24-4.65).
Within the RHI group, the schnauzer (OR 8.06, 95%CI 5.77-11.26) and Bichon Frise (OR 5.19, 95%CI 3.63-7.42) had increased odds of disease.
Dr Yuvani Bandara, corresponding author for the paper, said: “This is the first study to report the histopathological frequency of hepatobiliary diseases and to identify possible breed predispositions in a large cohort of dogs in the UK.
“Despite multivariable analysis not being performed to account for confounding factors, we hope that this information informs and supports future investigations for hepatic disease in particular breeds and potential predispositions.”
The full article can be found in the September issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13354.
'Evidence-based veterinary medicine at 20 – a commentary on historical, philosophical, practical, and ethical aspects' by David Mills MRCVS, Michael J. Reiss and Madeleine Campbell FRCVS, looks at the history of both evidence-based medicine and EBVM, the moral and ethical arguments for EBVM and the practical barriers.
It concludes that EBVM would be improved by:
Author David Mills MRCVS said: “EBVM has extensively infiltrated the veterinary discourse in the last 20 years and whilst it seems a sensible way of doing medicine, this doesn't always translate into practical improvements.
"Of course we need to base decisions on evidence, and the more reliable that evidence the better the decisions are likely to be.
"But is EBVM the best way?
"Does it serve the individual when the evidence doesn't relate to them or the specifics of their disease?
"Does EBVM help or hinder us in realising welfare improvements for the individual animal?
"In this review of the EBVM movement we examine aspects of the methodology and its practical application and in several areas find it wanting.
"Some of these are practical issues - for example underpowered studies, poor evidence - whilst others are fundamental to the philosophy and practice of EBVM itself such as what is evidence, how it translates to individuals and how we cannot predict the future.
"Evidence-based medicine was forged in the fires of not just accepting eminent pronouncements - in this paper we apply this principle to EBVM itself."
https://veterinaryevidence.org/index.php/ve/article/view/710
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
Ceva Animal Health has highlighted a new meta-analysis1 which, according to the company, reveals that there is a significant (P< 0.001) association between the use of pharmacotherapy (fluoxetine and clomipramine) or pheromonatherapy (Feliway) and reduction or elimination of feline urine marking.
Ceva says this is the first time a meta-analysis technique has been used to evaluate the efficacy of interventions in veterinary behavioural medicine; the study assessed all published papers covering treatments for feline urine spraying. Ten studies in nine publications were analysed, despite their different study designs. In order to carry out the meta-analysis, the papers were rated according to importance and a 'placebo-effect' was calculated. Primary and secondary outcomes were also identified, with the primary outcome being the 'number of cats that either ceased or reduced spraying by at least 90%' and the secondary outcome being 'the number of cats that reduce spraying from baseline levels'.
Information is available by calling Lucy Brett at CEVA Animal Health on 01494 781510.
1. A meta-analysis of studies of treatments for feline urine spraying. Daniel S Mills, Sarah E Redgate, Gary M Landsberg. PLos ONE, April 2011, Volume 6, Issue 4
An ectoparasitology working group has been set up to provide a set of practical guidelines for veterinary surgeons across Europe.
The group, which has been established to bring together best practice strategies in the light of changing ectoparasite threats met for the first time earlier this year.
Headed by Doctor Marie-Christine Cadiergues, lecturer, researcher and Professor in dermatology at the National Veterinary School of Toulouse in France, and hosted by Virbac, the group of six leading independent experts from across Europe - including Dr Ross Bond from the RVC - has been tasked with developing strategies which can be applied by vets when advising their clients.
Virbac's small animal ectoparasitology product manager Victoria Hudson explains that using evidence-based data where possible, the aim of the group is to produce a clear, practical set of guidelines: "These will cover treatment efficacy, practicability for client education and compliance, impact in terms of animal welfare, public health and potential resistance, and a decision tree covering a wide range of scenario presentations to define the optimal antiparasitic treatment options."
Dr Bond adds that despite the very common occurrence of flea and tick infestations in pets, control strategies can be challenging depending on individual circumstances of the case: "It is anticipated that these guidelines will assist busy veterinary practitioners in their selection of the optimal control strategy."
An initial report is expected in the press in a few weeks time.
Ceva Animal Health has rebranded its nutraceutical supplements for cats and dogs under its Logic brand.
The new Logic range, which previously included the company's dental products, now includes Logic Diar-Stop (previously known as Diarsanyl Plus) for digestive health, Logic Flexivet, a joint supplement and Logic Senilife, a nutraceutical which Ceva says has been shown to manage the signs of brain ageing.
The range is available in consumer-friendly packaging and a merchandising unit is available to showcase the products in practice.
Claire Russell, consumer product manager at Ceva Animal Health said: "The new Logic range provides veterinary practices with an extensive portfolio of respected veterinary strength supplements and dental products, with more exciting and innovative products to come in the pipeline."
For further information on the Logic range, visit www.logicforpets.co.uk, contact your local Ceva Animal Health territory manager or call Ceva's customer support team on 01494 781510.
There are 13 candidates standing in this year’s election for RCVS Council, the voting period for which will open on the week commencing Monday 14 March and close at 5pm on Friday 22 April 2022.
The candidates are:
The full biographies and manifesto statements for each candidate are available to read at www.rcvs.org.uk/vetvote22.
To submit a question to the candidates, email: vetvote22@rcvs.org.uk or post it on the RCVS Twitter account (@theRCVS) using the hashtag #vetvote22.
Candidates will then be asked to record a short video of themselves answering two questions of their choice which will be published when the election starts.
You have until Monday 21 February 2022 to submit your question.
The event, sponsored by Provet Cloud, will include interactive workshop sessions on ‘Finding Flexible Working Solutions’, ‘Financial Security and Negotiation Skills’, and ‘Developing Your Personal Brand’.
Women from all areas of the veterinary industry will also be sharing their inspirational career stories.
The speaker line-up for the event includes Flexee’s Silvia Janska, who takes a look at ‘Finding Flexible Working Solutions’, including how they can be implemented in practice to empower individuals and teams, and benefit the business.
Katie Ford and Paul Horwood from VetYou, will be addressing overcoming barriers in talking about, navigating, and creating security with money to arm delegates with negotiation tools and useable resources in their workshop session on ‘Financial Security and Negotiation Skills’
Hamzah Malik from Regent Animal Health will lead a workshop on ‘Developing Your Personal Brand’ to build delegates’ confidence in ways to explore and articulate personal identity and strengths, and apply brand marketing principles to boost career success.
The event will also feature ‘Seeing is Believing’ breakout sessions with female speakers from all spheres of veterinary practice, business, industry, nursing and education, sharing their career stories and taking part in Q&A sessions.
The event is suited to all those thinking about the next career step, considering leadership roles or already working within leadership positions in the veterinary sector.
Veterinary professionals and students can take advantage of an early-bird rate until 20th November.
For more information and to register for the event, visit: https://eu.eventscloud.com/website/7528/home/
There are two main streams – veterinary and nursing – alongside which there will be a number of workshops on dentistry, ophthalmology, electrosurgery and wound management
Speakers will include: Alasdair Hotston Moore, Matthew Oxford, David Williams, Sarah Heath and Molly Varga.
New for this year, there will be a separate two-day SPVS Leadership & Management programme (at extra charge) and interactive mental health sessions run by Vets in Mind.
There will also be sessions run by SCAS/Our Special Friends on 'the bond-centred practice'.
There's a commercial exhibition, a happy hour on day one, a hot buffet lunch, and tea, coffee and biscuits throughout both days.
For overnight accommodation, the organisers have secured a preferential rate (£125) at the on-site hotel – the Courtyard by Marriott – that includes breakfast and parking.
To book, use this link: https://www.marriott.com/event-reservations/reservation-link.mi?id=1709042444468&key=GRP&app=resvlink. There are lots of other options nearby.
Book directly at https://form.jotform.com/240863511432349.
To be invoiced rather than pay now, apply INVOICEME at checkout.
www.vetcpdcongress.co.uk.
A YouGov poll commissioned at the start of this month's National Vaccination Month Campaign by Intervet/Schering-Plough Animal Health has shown that pet vaccination rates nationally have remained stable between 2009 and 2011 despite the recession.
This could suggest that pet owners who do vaccinate generally accept that vaccination is not a discretionary item of spending which can be dropped in financially hard times. This is in contrast to worming, pet insurance and health checks, things which the survey found that between 6% and 9% of owners have cut back on.
Nevertheless, the survey supported industry data which shows that very considerable numbers of Britain's pets are left unvaccinated, with strong regional variations:
According to the YouGov survey, cost is a factor in more than 39% of cases where owners of a cat, dog, rabbit or horse are failing to vaccinate.
However, during National Vaccination Month, pet owners can download a voucher for a discounted vaccination offering savings of around £30 from participating surgeries throughout May. Unvaccinated and eligible dogs, cats, rabbits and horses are all included in the scheme and more than 2000 vet practices are taking part in the campaign nationwide.
Angus Robinson from Intervet/Schering-Plough Animal Health said: "The survey suggests that not only is there a demand for National Vaccination Month - 76% of those not vaccinating said they would take advantage of a scheme like this. But there is also a real need for client education. A staggering 91% of those polled said they would get their pet vaccinated if they were aware that there was disease in their area. Without wishing to scare people, we do need to alert pet owners to the fact that pet disease is out there. It is the kind of thing that they never think is going to happen to their beloved pet but when it does, it is devastating."
15.3% said they had received written abuse and 13.4% had received online abuse.
One in ten (9.87%) had cited receiving generally negative grumbles from their clients and a small percentage (0.8%) said they had noticed negativity from usually supportive clients.
17% reported abuse relating to the CMA across more than one platform.
On the other hand, the survey also revealed that 22.4% had received support in person, almost one in twenty (4.5%) had received online support, and 2.4% cited they had received supportive correspondence.
A report published by the Environmental, Food and Rural Affairs committee this week has concluded that The Veterinary Surgeons Act 1966 is in need of updating. However, lack of available budget in the current Comprehensive Spending Review period means that further work on a White Paper won't happen till 2011 at the earliest. In particular, the report found consensus within the profession that the disciplinary procedure is in urgent need of updating. However, the Royal College of Veterinary Surgeons does not have majority support for its proposals on compulsory practice standards and compulsory continuing professional development. The report crticised the RCVS for not having done enough to provide a clear picture of its proposals for a new statutory framework for the regulation of the profession. However, an RCVS spokesman said: "In fact, we have invested considerable time and resources in the development of proposals, led by a working party that included stakeholders. However, we have been awaiting further input from Defra before taking matters further." Chairman of the Committee the Rt Hon Michael Jack said: "We urge the profession to coalesce round some specific proposals to amend the disciplinary process for veterinary professionals. We believe that a working party should be set up between Defra, the Royal College of Veterinary Surgeons and the British Veterinary Association to produce a new Bill for introduction in 2009." Responding to the publication of the report, BVA President Nick Blayney said: "While we will certainly consider EFRACom’s proposal that BVA work with Defra and RCVS to produce a draft bill, the BVA is a voluntary association and our focus is the benefit of our members. Given that we are not even persuaded of the need for a new Act, it is likely that our contribution will be advisory and not financial." Click here for the full report